Safety of Antidiabetic Therapies on Bone

doi 10.1007/978-3-319-16402-1_7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer International Publishing

Related search

FDA Guidance on Cardiovascular Risk of Antidiabetic Therapies: One Decade Later

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

The Impact of Graphene Oxide on Bone Regeneration Therapies

2016English

Bone-Targeted Therapies in Cancer-Induced Bone Disease

Calcified Tissue International
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2017English

Cardiovascular Safety of Oral Antidiabetic Agents: The Insulin Secretagogues

Clinical Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

Comparative Analysis of Therapeutic Efficiency and Costs (Experience in Bulgaria) of Oral Antidiabetic Therapies Based on Glitazones and Gliptins

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

The Current and Future Therapies of Bone Regeneration to Repair Bone Defects

International Journal of Dentistry
Dentistry
2012English

Bayesian Meta-Experimental Design: Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Biometrics
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2011English

Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy

Drug Development Research
Drug Discovery
2015English

Comparing Drug Safety of Hepatitis C Therapies Using Post-Market Data

BMC Medical Informatics and Decision Making
Health PolicyHealth Informatics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy